8788711000001105: Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Lithium citrate\Product containing only lithium citrate in oral dose form (medicinal product form)\Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Lithium citrate\Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)
\UK product\Trade family\Li-Liquid\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing metal and/or metallic compound (product)\Product containing lithium and/or lithium compound (product)\Product containing lithium citrate\Lithium citrate\Product containing only lithium citrate in oral dose form (medicinal product form)\Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing metal and/or metallic compound (product)\Product containing lithium and/or lithium compound (product)\Product containing lithium citrate\Lithium citrate\Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing metal and/or metallic compound (product)\Product containing lithium and/or lithium compound (product)\Product containing lithium citrate\Product containing lithium citrate in oral dose form (medicinal product form)\Product containing only lithium citrate in oral dose form (medicinal product form)\Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing lithium citrate in oral dose form (medicinal product form)\Product containing only lithium citrate in oral dose form (medicinal product form)\Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution\Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

21212901000001111 Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

21213001000001119 Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Is a	Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has active ingredient	Lithium citrate	false	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has excipient	Paraben and/or paraben derivative	false	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Is a	Li-Liquid	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has excipient	Hydroxybenzoates	false	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has specific active ingredient	Lithium citrate	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) 150 ml	Is pack of	False	Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) 150 ml	Has AMP	True	Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
21212901000001111	Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
21213001000001119	Li-Liquid 509mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module